Clinical trial
Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant…
NCT00401024 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed
Key facts
| NCT number | NCT00401024 |
|---|---|
| Title | Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma |
| Official title | Determination of the In-Tumor-Concentration of Imatinib Mesylate in Malignant Glioma After Oral Administration |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Other, Procedure |
| Interventions | imatinib mesylate, pharmacological study, conventional surgery |
| Enrollment | 3 |
| Start date | Oct 12, 2006 |
| Primary completion | Feb 4, 2008 |
| Completion | Nov 11, 2008 |
| First posted | Nov 17, 2006 |
| Last update posted | Jun 28, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: